Published in CA Cancer J Clin on January 07, 2014
Tarceva With or Without Apatinib in the Advanced Lung Adenocarcinoma | NCT02704767
LDCT Screening in Non-smokers in Taiwan | NCT02611570
Neoadjuvant Hiltonol® (PolyICLC) for Prostate Cancer | NCT03262103
Prior Axitinib as a Determinant of Outcome of Renal Surgery (PADRES) | NCT03438708
Clinical Diagnostic Approach for Cases of Thyroid Nodules | NCT03884140
Examination of Focal Therapies- MRI-Fusion, HIFU, NanoKnife and Cryotherapy | NCT03982706
ACH-TH vs EC-TH as Neoadjuvant Therapy for HER2-positive EBC | NCT04172259
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA (2014) 6.32
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer. N Engl J Med (2015) 5.57
Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base. J Clin Oncol (2015) 4.58
The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging (2014) 3.40
Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison. J Clin Oncol (2015) 2.93
Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study. J Clin Oncol (2015) 2.70
Impact of hepatitis C virus eradication on hepatocellular carcinogenesis. Cancer (2015) 2.67
Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials. J Nucl Med (2015) 2.47
The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy. Eur Urol (2014) 2.26
Aerodigestive fistula formation as a rare side effect of antiangiogenic tyrosine kinase inhibitor therapy for thyroid cancer. Thyroid (2014) 2.25
Plk1 inhibition enhances the efficacy of androgen signaling blockade in castration-resistant prostate cancer. Cancer Res (2014) 2.23
Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer Survivors. J Clin Oncol (2015) 2.22
Should small papillary thyroid cancer be observed? A population-based study. Cancer (2014) 2.21
Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study. Lancet Oncol (2014) 2.18
Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer. Clin Cancer Res (2015) 2.09
Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer. J Clin Oncol (2015) 2.08
PBI-05204, a supercritical CO₂ extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathway. Invest New Drugs (2014) 2.04
Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer. Mol Imaging Biol (2015) 1.90
SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma. J Clin Oncol (2015) 1.87
Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma. J Clin Oncol (2015) 1.86
The growth of acute kidney injury: a rising tide or just closer attention to detail? Kidney Int (2014) 1.80
Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer. Gastroenterology (2014) 1.78
Extracellular metabolic energetics can promote cancer progression. Cell (2015) 1.74
Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev (2014) 1.73
Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ. J Natl Cancer Inst (2015) 1.72
Noninvasive Computed Tomography-based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial. Am J Respir Crit Care Med (2015) 1.70
Radiomics: Images Are More than Pictures, They Are Data. Radiology (2015) 1.68
The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis. PLoS One (2014) 1.64
DNA methyltransferases: a novel target for prevention and therapy. Front Oncol (2014) 1.62
A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas. Cancer Cell (2015) 1.61
Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation. Genes Dev (2015) 1.58
Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases. Cancer (2015) 1.57
CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma. Radiother Oncol (2015) 1.56
Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions. J Clin Oncol (2015) 1.56
Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1. Sci Signal (2015) 1.52
High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer. J Clin Oncol (2015) 1.52
Retracted Chicory (Cichorium intybus L.) root extract regulates the oxidative status and antioxidant gene transcripts in CCl4-induced hepatotoxicity. PLoS One (2015) 1.50
Genome-wide association study identifies shared risk loci common to two malignancies in golden retrievers. PLoS Genet (2015) 1.49
Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer. JAMA Oncol (2016) 1.49
Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older. Blood (2015) 1.49
P2X7 mediates ATP-driven invasiveness in prostate cancer cells. PLoS One (2014) 1.48
Serial Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: Incremental Value. J Urol (2015) 1.48
A systems genetics approach identifies CXCL14, ITGAX, and LPCAT2 as novel aggressive prostate cancer susceptibility genes. PLoS Genet (2014) 1.48
Tumor Lysis Syndrome in Solid Tumors: An up to Date Review of the Literature. Rare Tumors (2014) 1.48
MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer. PLoS One (2015) 1.46
Colorectal cancer screening and prevention in women. Dig Dis Sci (2015) 1.46
A rising trend in the incidence of advanced gastric cancer in young Hispanic men. Gastric Cancer (2016) 1.46
Magnetic nanoparticles with high specific absorption rate of electromagnetic energy at low field strength for hyperthermia therapy. J Appl Phys (2015) 1.46
Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer. Oncology (2016) 1.45
Smoking and risk of low- and high-grade prostate cancer: results from the REDUCE study. Clin Cancer Res (2014) 1.45
Doxycycline Induces Apoptosis and Inhibits Proliferation and Invasion of Human Cervical Carcinoma Stem Cells. PLoS One (2015) 1.44
Adjusted Age-Adjusted Charlson Comorbidity Index Score as a Risk Measure of Perioperative Mortality before Cancer Surgery. PLoS One (2016) 1.43
Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies. PLoS One (2016) 1.42
Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases. Cancer (2015) 1.42
Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth. Cancer Cell Int (2016) 1.42
Differential expression of miR-21 and miR-75 in esophageal carcinoma patients and its clinical implication. Am J Transl Res (2016) 1.41
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nat Genet (2014) 1.41
Expression and functional role of orphan receptor GPR158 in prostate cancer growth and progression. PLoS One (2015) 1.41
The expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancer. J Transl Med (2015) 1.41
Spectrum of Cerebrovascular Disease in Patients with Multiple Myeloma Undergoing Chemotherapy-Results of a Case Control Study. PLoS One (2016) 1.40
Colorectal cancer screening: will non-invasive procedures triumph? Genome Med (2014) 1.40
A panel of four genes accurately differentiates benign from malignant thyroid nodules. J Exp Clin Cancer Res (2016) 1.40
Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells. Cancer Cell Int (2016) 1.40
Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer. J Immunother Cancer (2017) 1.39
APC selectively mediates response to chemotherapeutic agents in breast cancer. BMC Cancer (2015) 1.39
Video-assisted thoracic surgery right sleeve lobectomy. J Thorac Dis (2014) 1.39
The optimal time for surgery in women with serous ovarian cancer. Can J Surg (2016) 1.39
Herniation formation in women undergoing robotically assisted laparoscopy or laparotomy for endometrial cancer. Gynecol Oncol (2016) 1.39
Performance of partial cystectomy in the United States from 2001 to 2010: trends and comparative outcomes. Can J Urol (2014) 1.39
Radioimmunotherapy consolidation using (131)I-tositumomab for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma in first remission. Leuk Lymphoma (2015) 1.38
Immunohistochemical Typing of Adenocarcinomas of the Pancreatobiliary System Improves Diagnosis and Prognostic Stratification. PLoS One (2016) 1.38
The melanoma revolution: from UV carcinogenesis to a new era in therapeutics. Science (2014) 1.37
A prospective, randomized, double-blind, placebo controlled trial on the efficacy of ethanol celiac plexus neurolysis in patients with operable pancreatic and periampullary adenocarcinoma. J Am Coll Surg (2014) 1.37
Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010. Cancer (2014) 1.37
Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis. Nat Cell Biol (2015) 1.36
Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups. Carcinogenesis (2014) 1.36
Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma. Cancer Immunol Res (2015) 1.35
Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia. Cancer Discov (2015) 1.34
Spectral-spatial classification for noninvasive cancer detection using hyperspectral imaging. J Biomed Opt (2014) 1.28
Acute hospital care is the chief driver of regional spending variation in Medicare patients with advanced cancer. Health Aff (Millwood) (2014) 1.28
The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma. Oncotarget (2015) 1.27
Assessment of Breast Cancer Patients' Knowledge and Decisional Conflict Regarding Tamoxifen Use. J Korean Med Sci (2015) 1.26
Exceptional opportunities in medical science: a view from the National Institutes of Health. JAMA (2015) 1.25
Expected population impacts of discontinued prostate-specific antigen screening. Cancer (2014) 1.24
Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine? Ann Transl Med (2014) 1.24
LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer. Oncotarget (2015) 1.23
ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism. J Clin Invest (2014) 1.22
¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer. J Nucl Med (2015) 1.21
Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer. Cancer Res (2014) 1.20
The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs. Oncotarget (2015) 1.20
Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases. Clin Transl Med (2015) 1.20
The influence of marital status on stage at diagnosis and survival of patients with colorectal cancer. Oncotarget (2015) 1.19
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients. Oncotarget (2016) 1.19
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51
Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin (2011) 30.81
Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin (2012) 14.47
Colorectal cancer statistics, 2014. CA Cancer J Clin (2014) 12.86
Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin (2004) 12.55
Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin (2014) 11.09
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst (2005) 8.36
International variation in prostate cancer incidence and mortality rates. Eur Urol (2012) 8.04
Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res (2006) 7.67
Breast cancer statistics, 2013. CA Cancer J Clin (2013) 7.35
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst (2003) 7.06
Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer (2007) 6.84
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol (2012) 6.37
Breast cancer statistics, 2011. CA Cancer J Clin (2011) 6.12
Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer (2002) 6.08
Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin (2007) 5.67
Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer (2009) 5.55
Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin (2007) 5.31
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 5.09
Cancer mortality in the United States by education level and race. J Natl Cancer Inst (2007) 4.77
Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin (2006) 4.73
Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer (2006) 4.71
Worldwide variations in colorectal cancer. CA Cancer J Clin (2009) 4.71
International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev (2009) 4.49
Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer (2013) 4.24
Validation of verbal autopsy procedures for adult deaths in China. Int J Epidemiol (2005) 4.20
Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin (2012) 4.13
The global burden of cancer: priorities for prevention. Carcinogenesis (2009) 3.73
Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin (2014) 3.59
Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin (2012) 3.58
Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer (2012) 3.55
Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev (2009) 3.08
Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med (2005) 3.02
Validation of cause-of-death statistics in urban China. Int J Epidemiol (2007) 2.89
Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst (2006) 2.66
Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol (2011) 2.58
Estimating average annual percent change for disease rates without assuming constant change. Biometrics (2006) 2.51
Cancer statistics for African Americans. CA Cancer J Clin (2002) 2.45
Cancer statistics for African Americans, 2013. CA Cancer J Clin (2013) 2.44
International trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers Prev (2011) 2.40
Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev (2012) 2.39
Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst (2002) 2.38
Trends in breast cancer by race and ethnicity. CA Cancer J Clin (2004) 2.19
Breast cancer incidence rates in U.S. women are no longer declining. Cancer Epidemiol Biomarkers Prev (2011) 2.06
Tobacco control in the United States--recent progress and opportunities. CA Cancer J Clin (2009) 1.97
The influence of sex, race/ethnicity, and educational attainment on human immunodeficiency virus death rates among adults, 1993-2007. Arch Intern Med (2012) 1.92
Cancer statistics for Hispanics, 2003. CA Cancer J Clin (2003) 1.88
Recent trends in Black-White disparities in cancer mortality. Cancer Epidemiol Biomarkers Prev (2008) 1.86
Pancreatic cancer death rates by race among US men and women, 1970-2009. J Natl Cancer Inst (2013) 1.85
Incidence of noncutaneous melanomas in the U.S. Cancer (2005) 1.85
Evaluating national cause-of-death statistics: principles and application to the case of China. Bull World Health Organ (2005) 1.83
Smoking among adolescents in China: 1998 survey findings. Int J Epidemiol (2004) 1.81
How much of the decrease in cancer death rates in the United States is attributable to reductions in tobacco smoking? Tob Control (2006) 1.80
Validation of a model of lung cancer risk prediction among smokers. J Natl Cancer Inst (2006) 1.55
State disparities in colorectal cancer mortality patterns in the United States. Cancer Epidemiol Biomarkers Prev (2011) 1.54
Trends in the incidence of colorectal cancer in relation to county-level poverty among blacks and whites. J Natl Med Assoc (2008) 1.42
A new method of predicting US and state-level cancer mortality counts for the current calendar year. CA Cancer J Clin (2004) 1.42
Management trends in stage I testicular seminoma: Impact of race, insurance status, and treatment facility. Cancer (2014) 1.41
Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Biomarkers Prev (2012) 1.36
Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001. J Natl Cancer Inst (2008) 1.34
A new method of estimating United States and state-level cancer incidence counts for the current calendar year. CA Cancer J Clin (2007) 1.33
Trends in colorectal cancer incidence rates by age, race/ethnicity, and indices of access to medical care, 1995–2004 (United States). Cancer Causes Control (2009) 1.33
U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortality. Cancer Epidemiol Biomarkers Prev (2011) 1.31
Cancer incidence patterns among adolescents and young adults in the United States. Cancer Causes Control (2005) 1.25
Second-hand tobacco smoke in public places in urban and rural China. Tob Control (2007) 1.23
Widening socioeconomic disparities in cervical cancer mortality among women in 26 states, 1993-2007. Cancer (2012) 1.21
Association of cutaneous melanoma incidence with area-based socioeconomic indicators-United States, 2004-2006. J Am Acad Dermatol (2011) 1.20
Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006. J Am Acad Dermatol (2011) 1.20
Subsite-specific colorectal cancer incidence rates and stage distributions among Asians and Pacific Islanders in the United States, 1995 to 1999. Cancer Epidemiol Biomarkers Prev (2004) 1.19
An age-stratified poisson model for comparing trends in cancer rates across overlapping regions. Biom J (2008) 1.19
A Weighted-Least-Squares Estimation Approach to Comparing Trends in Age-Adjusted Cancer Rates Across Overlapping Regions. J Data Sci (2011) 1.18
Body mass index in young adulthood and premature death: analyses of the US National Health Interview Survey linked mortality files. Am J Epidemiol (2011) 1.15
Disparities in breast cancer prognostic factors by race, insurance status, and education. Cancer Causes Control (2010) 1.15
Predicting US- and state-level cancer counts for the current calendar year: Part II: evaluation of spatiotemporal projection methods for incidence. Cancer (2012) 1.14
Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004-2006. Cancer Epidemiol Biomarkers Prev (2010) 1.12
Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades. Cancer (2013) 1.11
Temporal trends in breast cancer mortality by state and race. Cancer Causes Control (2008) 1.11
Cotinine concentration in smokers from different countries: relationship with amount smoked and cigarette type. Cancer Epidemiol Biomarkers Prev (2006) 1.10
Age-specific trends in black-white disparities in cervical cancer incidence in the United States: 1975-2009. Gynecol Oncol (2012) 1.05
Insurance status is related to diffuse large B-cell lymphoma survival. Cancer (2014) 1.04
Interpreting cancer trends. Ann N Y Acad Sci (2006) 1.03
An urban-rural comparison of the prevalence of the metabolic syndrome in Eastern China. Public Health Nutr (2007) 1.03
Out of view but in plain sight: the illegal sale of single cigarettes. J Urban Health (2014) 1.02
U.S. congressional district cancer death rates. Int J Health Geogr (2006) 1.00
Increasing lung cancer death rates among young women in southern and midwestern States. J Clin Oncol (2012) 0.97
Determinants of salivary cotinine concentrations in Chinese male smokers. Prev Med (2003) 0.97
AACR Cancer Progress Report 2013. Clin Cancer Res (2013) 0.95
The rise and fall of cancer mortality in the USA: why does pancreatic cancer not follow the trend? Future Oncol (2013) 0.95
Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010-2011). Breast Cancer Res Treat (2014) 0.95